about
A role for galanin N-terminal fragment (1-15) in anxiety- and depression-related behaviors in rats.IGF-II promotes neuroprotection and neuroplasticity recovery in a long-lasting model of oxidative damage induced by glucocorticoids.Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and DiseaseLong-lasting memory deficits in mice withdrawn from cocaine are concomitant with neuroadaptations in hippocampal basal activity, GABAergic interneurons and adult neurogenesisGalanin receptor/neuropeptide y receptor interactions in the central nervous system.Galanin (1-15) enhancement of the behavioral effects of Fluoxetine in the forced swimming test gives a new therapeutic strategy against depression.The neuropeptides Galanin and Galanin(1-15) in depression-like behaviours.On the existence and function of galanin receptor heteromers in the central nervous systemCentral administration of galanin N-terminal fragment 1-15 decreases the voluntary alcohol intake in rats.Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions.Galanin (1-15) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system.Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the dentate gyrus are related with antidepressant-like effects.Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex.A Novel Integrative Mechanism in Anxiolytic Behavior Induced by Galanin 2/Neuropeptide Y Y1 Receptor Interactions on Medial Paracapsular Intercalated Amygdala in Rats.Receptor⁻Receptor Interactions in Multiple 5-HT1A Heteroreceptor Complexes in Raphe-Hippocampal 5-HT Transmission and Their Relevance for Depression and Its Treatment.Galanin receptor/Neuropeptide Y receptor interactions in the dorsal raphe nucleus of the ratThe Galanin N-terminal fragment (1–15) interacts with neuropeptide Y in central cardiovascular control: Involvement of the NPY Y2 receptor subtypeRole of the galanin N-terminal fragment (1-15) in anhedonia: Involvement of the dopaminergic mesolimbic system
P50
Q30627955-40BA9B81-36DC-46D4-880E-410BDFAA258BQ33753428-67E36DC1-87B1-4D06-933E-2EB19C3B96D2Q36300230-AF663F04-BDD8-4C76-8966-8AEE88F34730Q37731162-DEF3A7F7-C009-43ED-A805-2CE79A6F9DEDQ38245069-257D6971-F744-465D-9303-374E3CD65F64Q38910583-C276EC95-077B-4F7D-8EF9-A214A88FC57CQ38961819-23914D47-2BDC-4DC7-9BF9-1B23C728B47CQ41889343-D96E23D8-1593-4200-91D1-C992F727B978Q47567119-8B1BE9A7-1961-4A00-869E-1017C31B575DQ47768591-00BAAC02-F673-462C-913C-2F576CB8596FQ48065901-D190679D-773F-4483-8547-F3404FA1198DQ48068641-0C3BA297-4A56-4DF0-8573-001B453A98B9Q48227093-43616038-BE39-4F0B-A9D3-7DAA2E08FD10Q53820290-8BEFEA00-A568-4BAA-BE87-6CE466B1F898Q54977137-74019320-6423-4EBD-ABD0-4EF0AA604E72Q60488851-5B6B7997-19FD-4AF9-ACF6-04A0DB7658AEQ60488856-D73E0DE1-CB91-43D8-938E-4568FEE71A8CQ91969022-8F34F29C-5EC6-4F16-9F58-E3A054826A41
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carmelo Millón
@ast
Carmelo Millón
@en
Carmelo Millón
@es
Carmelo Millón
@nl
Carmelo Millón
@sl
type
label
Carmelo Millón
@ast
Carmelo Millón
@en
Carmelo Millón
@es
Carmelo Millón
@nl
Carmelo Millón
@sl
altLabel
Carmelo Millón Peñuela
@en
Millon C.
@en
Millon Peñuela C.
@en
Millón C.
@en
Millón Peñuela C.
@en
Millón Peñuela Carmelo
@en
prefLabel
Carmelo Millón
@ast
Carmelo Millón
@en
Carmelo Millón
@es
Carmelo Millón
@nl
Carmelo Millón
@sl
P1053
K-3485-2017
P106
P1153
36437586100
P1960
xxevygIAAAAJ
P21
P2798
P31
P3829
P3835
carmelo-milln
P496
0000-0001-7580-5506
P569
2000-01-01T00:00:00Z